Spacelabs Announces 6 Monthy Results
Spacelabs reported interim financial results yesterday. They appear to be doing well; revenue is up 16% to $112.4 million, patient monitoring orders are up 15%, operating income is up a whopping 57% to $6.5 million. Net income is up 50% to $4.1 million. Their IPO on the London AIM market raised $26.3 million net. Operating highlights:
- Awarded a three-year, multi-source supplier contract with Premier,
Inc., one of the US's leading hospital and healthcare system alliances; - Launched a wireless network option for the range of UltraviewSL 2400 compact monitors in North America;
- Received 510(k) approval from the US FDA for distribution of the
Blease Sirius anesthesia system into the US market — expected to be
launched into the US market in 2007; - Continued gross margin
improvement driven by new patient monitoring products and manufacturing
efficiencies in the anesthesia product line.
